Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL
NCT05269914
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B Cell Lymphoma
Interventions
OTHER:
Autologous anti-CD19 CAR-T cell injection
Sponsor
The Affiliated Hospital of Qingdao University